{"cord_uid": "izxhiusf", "sourcedb": "PMC", "sourceid": "PMC3420249", "divid": "23", "text": "Thirty - three children , 12 girls and 21 boys with a median age of 10 months ( range 4 - 38 m ) , were assessed because of unexplained persistent wheezing despite ICS therapy . Administrated ICS dosages ranged from 100 - 500 mcg fluticasone daily or equivalent , with a variable treatment duration of 1 - 10 months . Table 1 summarises the characteristics of the study population with respect to allergy and reflux testing results , and familial and environmental risk factors for asthma . Only 7 of 13 ( 53 . 8 % ) children suffering from gastro - oesophageal reflux disease ( GERD ) , were treated for GERD prior to FOB + BAL .", "project": "cdlai_CORD-19", "denotations": [{"id": "A-biobert_T1", "span": {"begin": 147, "end": 156}, "obj": "Disease"}, {"id": "A-biobert_T2", "span": {"begin": 482, "end": 489}, "obj": "Disease"}, {"id": "A-biobert_T3", "span": {"begin": 541, "end": 577}, "obj": "Disease"}, {"id": "A-biobert_T4", "span": {"begin": 579, "end": 584}, "obj": "Disease"}, {"id": "A-biobert_T5", "span": {"begin": 605, "end": 610}, "obj": "Disease"}]}